HUTCHMED (China) Statistics
Total Valuation
HCM has a market cap or net worth of $2.59 billion. The enterprise value is $1.39 billion.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HCM has 859.30 million shares outstanding. The number of shares has increased by 2.18% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 859.30M |
| Shares Change (YoY) | +2.18% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 26.17% |
| Float | 509.04M |
Valuation Ratios
The trailing PE ratio is 5.55 and the forward PE ratio is 11.03.
| PE Ratio | 5.55 |
| Forward PE | 11.03 |
| PS Ratio | 4.30 |
| Forward PS | n/a |
| PB Ratio | 2.09 |
| P/TBV Ratio | 2.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 2.98 |
| EV / Sales | 2.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.65, with a Debt / Equity ratio of 0.08.
| Current Ratio | 4.65 |
| Quick Ratio | 4.47 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.86 |
Financial Efficiency
Return on equity (ROE) is 46.90% and return on invested capital (ROIC) is -1.13%.
| Return on Equity (ROE) | 46.90% |
| Return on Assets (ROA) | -0.81% |
| Return on Invested Capital (ROIC) | -1.13% |
| Return on Capital Employed (ROCE) | -1.37% |
| Revenue Per Employee | $332,522 |
| Profits Per Employee | $257,803 |
| Employee Count | 1,811 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 11.56 |
Taxes
In the past 12 months, HCM has paid $67.47 million in taxes.
| Income Tax | 67.47M |
| Effective Tax Rate | 12.61% |
Stock Price Statistics
The stock price has decreased by -18.55% in the last 52 weeks. The beta is 0.48, so HCM's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -18.55% |
| 50-Day Moving Average | 15.73 |
| 200-Day Moving Average | 15.36 |
| Relative Strength Index (RSI) | 43.99 |
| Average Volume (20 Days) | 32,046 |
Short Selling Information
| Short Interest | 363,798 |
| Short Previous Month | 374,511 |
| Short % of Shares Out | 0.35% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.51 |
Income Statement
In the last 12 months, HCM had revenue of $602.20 million and earned $466.88 million in profits. Earnings per share was $0.53.
| Revenue | 602.20M |
| Gross Profit | 53.76M |
| Operating Income | -19.70M |
| Pretax Income | 535.03M |
| Net Income | 466.88M |
| EBITDA | -7.49M |
| EBIT | -19.70M |
| Earnings Per Share (EPS) | $0.53 |
Full Income StatementBalance Sheet
The company has $1.37 billion in cash and $100.73 million in debt, giving a net cash position of $1.26 billion or $1.47 per share.
| Cash & Cash Equivalents | 1.37B |
| Total Debt | 100.73M |
| Net Cash | 1.26B |
| Net Cash Per Share | $1.47 |
| Equity (Book Value) | 1.24B |
| Book Value Per Share | 1.43 |
| Working Capital | 1.25B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$32.57 million and capital expenditures -$17.09 million, giving a free cash flow of -$49.66 million.
| Operating Cash Flow | -32.57M |
| Capital Expenditures | -17.09M |
| Free Cash Flow | -49.66M |
| FCF Per Share | -$0.06 |
Full Cash Flow StatementMargins
Gross margin is 8.93%, with operating and profit margins of -3.27% and 77.53%.
| Gross Margin | 8.93% |
| Operating Margin | -3.27% |
| Pretax Margin | 88.85% |
| Profit Margin | 77.53% |
| EBITDA Margin | -1.24% |
| EBIT Margin | -3.27% |
| FCF Margin | n/a |
Dividends & Yields
HCM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.18% |
| Shareholder Yield | -2.18% |
| Earnings Yield | 18.02% |
| FCF Yield | -1.92% |
Dividend DetailsAnalyst Forecast
The average price target for HCM is $13.75, which is -7.97% lower than the current price. The consensus rating is "Sell".
| Price Target | $13.75 |
| Price Target Difference | -7.97% |
| Analyst Consensus | Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 22.58% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCM has an Altman Z-Score of 4.01 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.01 |
| Piotroski F-Score | 3 |
